Deleterious Synergistic Effects of Ascorbate and Copper on the Development of Plasmodium Falciparum: an in Vitro Study in Normal and in G6PD-deficient Erythrocytes
Overview
Authors
Affiliations
The effects of ascorbate and copper on the development of Plasmodium falciparum were studied in two modes: pretreatment of uninfected erythrocytes followed by infection by P. falciparum and treatment of parasitized erythrocytes. Pretreatment of G6PD(+) cells with ascorbate caused a slight enhancement in parasite development, while in G6PD(-) cells a suppressive effect on the plasmodia was demonstrated. Copper alone interfered with parasite growth in both cell types. The combination of copper and ascorbate arrested parasite maturation, an effect which was more pronounced in G6PD(-) cells. Synergism between copper and ascorbate was better demonstrated following the treatment of infected erythrocytes: while ascorbate alone supported parasite development and copper alone had only a marginal suppressive effect, the combination of copper and ascorbate yielded a marked inhibition of parasite growth. Ascorbate proved destructive to the parasites in the presence of adventitious copper, or on the second day of the parasite life cycle. In these cases it acted as a pro-oxidant, while in other systems, in particular in the presence of a chelator, ascorbate acted as an antioxidant and promoted parasite growth. The understanding of the role of transition metals and free radicals in parasite development and injury could shed light on novel approaches to fight malaria.
The zymogen of plasmepsin V from Plasmodium falciparum is enzymatically active.
Xiao H, Bryksa B, Bhaumik P, Gustchina A, Kiso Y, Yao S Mol Biochem Parasitol. 2014; 197(1-2):56-63.
PMID: 25447707 PMC: 6310130. DOI: 10.1016/j.molbiopara.2014.10.004.
The role of antioxidants treatment on the pathogenesis of malarial infections: a review.
Isah M, Ibrahim M Parasitol Res. 2014; 113(3):801-9.
PMID: 24525759 DOI: 10.1007/s00436-014-3804-1.
Rasoloson D, Shi L, Chong C, Kafsack B, Sullivan D Biochem J. 2004; 381(Pt 3):803-11.
PMID: 15125686 PMC: 1133890. DOI: 10.1042/BJ20040335.
Potentiation of an antimalarial oxidant drug.
Winter R, Ignatushchenko M, Ogundahunsi O, Cornell K, Oduola A, Hinrichs D Antimicrob Agents Chemother. 1997; 41(7):1449-54.
PMID: 9210664 PMC: 163938. DOI: 10.1128/AAC.41.7.1449.
On and beyond O2 binding: hemoglobin and myoglobin revisited.
Saltman P Experientia. 1995; 51(3):205-6.
PMID: 7698278 DOI: 10.1007/BF01931095.